Literature DB >> 25588959

Prospective evaluation of early postoperative male and female sexual function after radical prostatectomy with erectile nerves preservation.

S-N Tran1, G J Wirth1, G Mayor1, C Rollini2, F Bianchi-Demicheli2, C E Iselin1.   

Abstract

Prostate cancer screening has led to the diagnosis of localized prostate cancer in increasingly young and sexually active men. Accordingly, the impact of cancer treatment on sexual function is gaining more attention. To prospectively evaluate the impact of radical prostatectomy (RP) on male, female and conjugal sexual function. Patients were prospectively assessed by an urologist and a sexologist before and 6 months after robot-assisted laparoscopic RP (RALP). RALP was performed with uni- or bilateral neurovascular bundle preservation by a single surgeon. Postoperatively, all patients were prescribed tadalafil 20 mg, 3 times a week during 6 months. Male and female sexual functions were evaluated by using the International Index of Erectile Function (IIEF-5), the Female Sexual Function Index (FSFI) and the Lock-Wallace Marital Adjustment Test (MAT). Continuous variables were analyzed with rank-sum and t-tests, as needed, and categorical variables with chi-squared tests. All tests were two-sided, with a P-value ⩽ 0.05 considered significant. Twenty-one couples were included. Mean patient male and female age was 62.4 and 60.7 years, respectively. Bilateral nerve sparing was performed in 12/21 (57%) patients. Median preoperative IIEF-5 was 20/25, corresponding to mild erectile dysfunction (ED). Median preoperative FSFI and MAT were both within normal range (28/36 and 114/158, respectively). Six months following surgery, both IIEF-5 (11/25) and FSFI (25/36) had significantly dropped (P=0.007 and 0.003, respectively). Postoperative decreases in IIEF-5 and FSFI scores were associated within couples. MAT scores (115/158), however, remained unaffected by RALP, showing an unmodified relationship satisfaction postoperatively. Finally, bilateral nerve sparing surgery preserved not only male but also female sexual function. This study shows that the expected short-term post-RALP ED is associated with a worsening of female sexual function, whereas nerve sparing surgery has a protective effect on both the patient's and his partner's sexual function with a significant effect of bilateral over unilateral neurovascular bundle preservation. Furthermore, we found that conjugal complicity remains stable throughout the first semestrial postoperative period despite the decrease in sexual function.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25588959     DOI: 10.1038/ijir.2014.36

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  16 in total

1.  Time course of recovery of erectile function after radical retropubic prostatectomy: does anyone recover after 2 years?

Authors:  Farhang Rabbani; Jeffrey Schiff; Michael Piecuch; Luis Herran Yunis; James A Eastham; Peter T Scardino; John P Mulhall
Journal:  J Sex Med       Date:  2010-08-16       Impact factor: 3.802

2.  Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.

Authors:  Leonard Glickman; Guilherme Godoy; Herbert Lepor
Journal:  J Urol       Date:  2008-12-16       Impact factor: 7.450

Review 3.  Prophylaxis of erectile function after radical prostatectomy with phosphodiesterase type 5 inhibitors.

Authors:  F Deho; A Gallina; A Salonia; A Briganti; N Suardi; G Zanni; G Guazzoni; P Rigatti; F Montorsi
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

4.  Discriminating interaction behaviors in happy and unhappy marriages.

Authors:  G R Birchler; L J Webb
Journal:  J Consult Clin Psychol       Date:  1977-06

5.  Altered male physiologic function after surgery for prostate cancer: couple perspective.

Authors:  Matvey Tsivian; Janice M Mayes; Tracey L Krupski; Vladimir Mouraviev; Craig F Donatucci; Thomas J Polascik
Journal:  Int Braz J Urol       Date:  2009 Nov-Dec       Impact factor: 1.541

6.  Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.

Authors:  Eva Johansson; Gunnar Steineck; Lars Holmberg; Jan-Erik Johansson; Tommy Nyberg; Mirja Ruutu; Anna Bill-Axelson
Journal:  Lancet Oncol       Date:  2011-08-05       Impact factor: 41.316

7.  The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores.

Authors:  Markus Wiegel; Cindy Meston; Raymond Rosen
Journal:  J Sex Marital Ther       Date:  2005 Jan-Feb

8.  Prostate cancer: perspectives on quality of life and impact of treatment on patients and their partners.

Authors:  Helen Crowe; Anthony J Costello
Journal:  Urol Nurs       Date:  2003-08

9.  Psychosocial adaptation in female partners of men with prostate cancer.

Authors:  A F Street; J W Couper; A W Love; S Bloch; D W Kissane; B C Street
Journal:  Eur J Cancer Care (Engl)       Date:  2009-07-20       Impact factor: 2.520

10.  Penile rehabilitation protocol after robot-assisted radical prostatectomy: assessment of compliance with phosphodiesterase type 5 inhibitor therapy and effect on early potency.

Authors:  Daniel J Lee; Philippa Cheetham; Ketan K Badani
Journal:  BJU Int       Date:  2009-08-28       Impact factor: 5.588

View more
  3 in total

Review 1.  Predictors of Patient and Partner Satisfaction Following Radical Prostatectomy.

Authors:  Cailey Guercio; Akanksha Mehta
Journal:  Sex Med Rev       Date:  2017-11-08

Review 2.  Psychosocial contributors to patients' and partners' postprostate cancer sexual recovery: 10 evidence-based and practical considerations.

Authors:  Lauren M Walker
Journal:  Int J Impot Res       Date:  2020-11-17       Impact factor: 2.896

Review 3.  Erectile dysfunction.

Authors:  Faysal A Yafi; Lawrence Jenkins; Maarten Albersen; Giovanni Corona; Andrea M Isidori; Shari Goldfarb; Mario Maggi; Christian J Nelson; Sharon Parish; Andrea Salonia; Ronny Tan; John P Mulhall; Wayne J G Hellstrom
Journal:  Nat Rev Dis Primers       Date:  2016-02-04       Impact factor: 52.329

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.